Neurocrine Biosciences director Sherwin sells $1.6m in stock By Investing.com

Published on 14 Feb 2025 on Investing.com

SAN DIEGO—Stephen A. Sherwin, a director at Neurocrine Biosciences Inc. (NASDAQ:NBIX), a $11.4...

Read the rest of the article

Start tracking your investments with Statfolio

Over the last 7 days, the United States market has dropped 2.2%, yet it remains up by 18% over th...

Simply Wall St. · via Yahoo Finance 24 Feb 2025

We recently published a list of 15 Best Fast Growth Stocks To Buy Right Now. In this article, we ...

Insider Monkey · via Yahoo Finance 21 Feb 2025

Even though Neurocrine Biosciences, Inc. (NASDAQ:NBIX ) posted strong earnings, investors appeare...

Simply Wall St. · via Yahoo Finance 21 Feb 2025

We recently published a list of 10 Top Insider Stock Buys And Sells In January. In this article, ...

Insider Monkey · via Yahoo Finance 18 Feb 2025

Neurocrine Biosciences' SWOT analysis: navigating growth amid market shifts

Investing.com 18 Feb 2025

Eric Benevich, the Chief Commercial Officer of Neurocrine Biosciences Inc (NASDAQ:NBIX), recently...

Investing.com 14 Feb 2025

David W. Boyer, Chief Corporate Affairs Officer at Neurocrine Biosciences Inc. (NASDAQ:NBIX),...

Investing.com 14 Feb 2025

SAN DIEGO—Gano Kyle, the Chief Executive Officer of Neurocrine Biosciences Inc. (NASDAQ:NBIX), a...

Investing.com 14 Feb 2025

SAN DIEGO—Stephen A. Sherwin, a director at Neurocrine Biosciences Inc. (NASDAQ:NBIX), a $11.4...

Investing.com 14 Feb 2025

This ETF has heaviest allocation in the Healthcare sector--about 100% of the portfolio. Looking a...

Zacks · via Yahoo Finance 3 Feb 2025